M&A

Royalty Pharma stands by reduced Elan bid

Royalty Pharma stands by reduced Elan bid

Reuters

Allergan Evaluates Bids for its Lap-Band Weight Loss Product

Allergan Evaluates Bids for its Lap-Band Weight Loss Product

Bloomberg

On verge of $13B merger, Valeant and Actavis stop talking

On verge of $13B merger, Valeant and Actavis stop talking

Fierce Pharma

3 Biotech Companies Ripe for a Takeover

3 Biotech Companies Ripe for a Takeover

Motley Fool

Bayer to buy birth-control devices maker for $1.1 billion

Bayer to buy birth-control devices maker for $1.1 billion

Yahoo/Reuters

Valeant Pharmaceuticals in Talks to Buy Actavis

Valeant Pharmaceuticals in Talks to Buy Actavis

Wall Street Journal

Valeant completes tender offer for Obagi Medical

Valeant completes tender offer for Obagi Medical

Yahoo/Fly on the Wall

OPKO Health To Acquire PROLOR Biotech

OPKO Health To Acquire PROLOR Biotech

Yahoo

Elan sees sales of prized Tysabri drug rise sharply

Elan sees sales of prized Tysabri drug rise sharply

Reuters

Moody's sees pick-up in pharmaceutical industry M&A in 2013

Moody's sees pick-up in pharmaceutical industry M&A in 2013

Reuters